AIM: CER
Cerillion plc
("Cerillion" or the "Company")
Share Purchase
Cerillion plc, the billing, charging and customer relationship management software solutions provider, announces that it has purchased 21,500 shares of
Following this purchase, a total of 21,512 Ordinary Shares, representing 0.1 per cent of the voting rights attributable to the total Ordinary Shares in issue prior to the purchase, are held in treasury.
Total voting rights
Following the share purchase and for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares in issue is 29,491,986 with each share carrying the right to one vote.
The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.
Enquiries:
Cerillion plc |
c/o KTZ Communications |
Louis Hall, CEO |
T: 020 3178 6378 |
Andrew Dickson, CFO |
|
Panmure Liberum Limited (Nomad and Joint Broker) |
T: 020 3100 2000 |
Bidhi Bhoma, Edward Mansfield, Matthew Hogg |
|
Singer Capital Markets (Joint Broker) |
T: 020 7496 3000 |
Rick Thompson, James Fischer |
|
KTZ Communications |
T: 020 3178 6378 |
Katie Tzouliadis, Robert Morton |
|
About Cerillion
www.cerillion.com
Cerillion is a leading provider of mission critical software for billing, charging and customer relationship management, with a 23-year track record in providing comprehensive revenue and customer management solutions. The Company has around 80 customers across 45 countries, principally serving the telecommunications market.
The Company is headquartered in
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.